Resveratrol prevents NAFLD in offspring by reducing hepatic steatosis, improving metabolic signaling, and modulating RAS components including ↑ ACE2, ↓ ACE1/AT1R. The gene discussed is ACE2; the disease is metabolic dysfunction-associated steatotic liver disease.